N-Caffeoyltryptophan
CAS No. 109163-69-1
N-Caffeoyltryptophan( trans-Caffeoyl-L-tryptophan )
Catalog No. M29476 CAS No. 109163-69-1
N-Caffeoyltryptophan, a potential Sirt inhibitor, is screened using coffee extract. N-Caffeoyltryptophan inhibited Sirt2 (IC50; 8.7 μM) better than Sirt1(IC50; 34μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
|
10MG | 447 | Get Quote |
|
25MG | 714 | Get Quote |
|
50MG | 1017 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameN-Caffeoyltryptophan
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Caffeoyltryptophan, a potential Sirt inhibitor, is screened using coffee extract. N-Caffeoyltryptophan inhibited Sirt2 (IC50; 8.7 μM) better than Sirt1(IC50; 34μM).
-
DescriptionN-Caffeoyltryptophan, a potential Sirt inhibitor, is screened using coffee extract. N-Caffeoyltryptophan inhibited Sirt2 (IC50; 8.7 μM) better than Sirt1(IC50; 34μM).(In Vitro):In cellular levels,N-Caffeoyltryptophan was able to increase the acetylation of total lysine, cortactin and histone H3 in neuronal NG108-15 cells. In the same cells, the amide also increased the acetylation of lysine (K382) in p53, but not (K305).
-
In Vitro——
-
In Vivo——
-
Synonymstrans-Caffeoyl-L-tryptophan
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorSirtuin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number109163-69-1
-
Formula Weight366.373
-
Molecular FormulaC20H18N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)\C=C\c1ccc(O)c(O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SRT 1460
SRT1460 is a potent, selective SIRT1 activator with EC1.5 of 2.9 uM.
-
Fisetin
Extracted from Rhus succedanea L;Store the product in sealed, cool and dry condition.
-
RK-9123016
RK-9123016 is a SIRT2 inhibitor. RK-9123016 increases the acetylation level of eukaryotic translation initiation factor 5A (eIF5A), a physiological substrate of SIRT2, and reduces cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression.